Clinical Feasibility of Disease Managing Mobile App for Hyperthyroidism

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled study aims to investigate the effects of using a mobile app that integrates with wearable devices to monitor heart rate, check self-reported symptoms, provide disease-related information, and set medication reminders for patients with thyrotoxicosis. The study intends to evaluate how the use of the app affects disease progression, quality of life, and health-related behaviors associated with the disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Mobile Application on Hypothyroid Patients

NCT05708456

Hypothyroidism Symptom Management Symptoms and Signs +2 more

UNKNOWN NA

Biosignals by Wearable Devices in Hypothyroidism

NCT04332770

Hypothyroidism

COMPLETED

Evaluating an AI Tool for Detecting Thyrotoxic States

NCT07017907

Graves Disease Hyperthyroidism/Thyrotoxicosis

NOT_YET_RECRUITING

Heart Rate Monitoring by Wearable Devices in Graves' Disease

NCT04333342

Graves' Disease in Remission (Disorder)

UNKNOWN NA

Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis

NCT03009357

Thyrotoxicosis Graves Disease Thyroiditis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperthyroidism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

app user group

The participants in this group start using wearable devices to monitor their heart rate and a mobile app to assist with the management of hyperthyroidism after being diagnosed and beginning treatment with anti-thyroid medication.

Group Type EXPERIMENTAL

Using a mobile app that integrates with wearable devices

Intervention Type OTHER

Using a mobile app that integrates with wearable devices to monitor heart rate, check self-reported symptoms, provide disease-related information, and set medication reminders for patients with thyrotoxicosis.

non-user group

The participants in this group begin treatment with anti-thyroid medication after being diagnosed with thyrotoxicosis, but they do not use the wearable devices or mobile app used in this study.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Using a mobile app that integrates with wearable devices

Using a mobile app that integrates with wearable devices to monitor heart rate, check self-reported symptoms, provide disease-related information, and set medication reminders for patients with thyrotoxicosis.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who have been newly diagnosed or are currently undergoing treatment for thyrotoxicosis at Bundang Seoul National University Hospital.
* Subjects must be able to use the smartphone app required for the use of wearable devices and their integration.

Exclusion Criteria

* Subjects who have constraints on normal activity due to diseases other than thyroid dysfunction.
* Subjects who are currently taking medication that affects heart rate.
* Subjects with heart conditions such as arrhythmia that affect heart rate.
* Subjects who cannot undergo antithyroid drug treatment and require surgery or radioactive iodine therapy.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No